Loss of heterozygosity at 3p14.2 in Clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1323-1326

  Velickovic, Marija ^a   Delahunt, Brett ^a   Grebe, Stefan K G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTIDINE;

ARTICLE; CHROMOSOME 3P; CLEAR CELL CARCINOMA; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ADENOCARCINOMA, CLEAR CELL; CARCINOMA, RENAL CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEINS;

EID: 0033559942     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., and Wei, M. H. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7: 85-90, 1994.
2. Lubinski, J., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., McCue, P., Druck, T., and Huebner, K. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinoma. Cancer Res., 55: 5348-5353, 1995.
3. Willers, C. P., Siebert, R., Bardenheuer, W., Lux, A., Michaelis, S., Seeber, S., Opalka, B., and Schutte, J. Genetic instability of 3p12-p21-specific microsatellite sequences in renal cell carcinoma. Br. J. Urol., 77: 524-529, 1996.
4. Wilhelm, M., Bugert, P., Kenck, C., Staehler, G., and Kovacs, G. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res., 55: 5383-5385, 1995.
5. Smeets, D. F. C. M., Scheres, J. M. J. C., and Husinx, T. W. J. The most common fragile site in men is 3p14. Hum. Genet., 72: 215-220, 1986.
6. Cohen, A. J., Li, F. P., Berg, S., Marchetto, D. J., Tsai, S., Jacobs, S. C., and Brown, R. S. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med., 301: 592-595, 1979.
7. Boldog, F. L., Gemmill, R. M., Wilke, C. M., Glover, T. W., Nilsson, A. S., Chandrasekharappa, S. C., Brown, R. S., Li, F. P., and Drabkin, H. A. Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint. Proc. Natl. Acad. Sci. USA, 90: 8509-8513, 1993.
8. Paradee, W., Mullins, C., Zhanquan, H., Glover, T., Wilke, C., Opalka, B., Schutte, J., and Smith, D. I. Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3. Genomics, 27: 358-361, 1995.
9. Druck, T., Kastury, K., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., Ohta, M., LaForgia, S., Lasota, J., McCue, P., Lubinski, J., and Huebner, K. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res., 55: 5348-5353, 1995.
10. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
11. van den Berg, A., Hulsbeek, M. M. F., de Jong, D., Kok, K., Veldhuis, P. M. M. F., Roche, J., and Buys, C. H. C. M. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosomes Cancer. 15: 64-72, 1996.
12. Shridhar, V., Wang, L., Rosati, R., Paradee, W., Shridhar, R., Mullins, C., Sakr, W., Grignon, D., Miller, O. J., Sun, Q. C., Petros, J., and Smith, D. I. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene. 14: 1269-1277, 1997.
13. Bugert, P., Wilhelm, M., and Kovacs, G. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer. 20: 9-15, 1997.
14. Sobin, L. H., and Wiltekind, C. (eds.). International Union Against Cancer (UICC) TNM Classification of Malignant Tumors, pp. 180-182. New York: Wiley-Liss, 1997.
15. Fuhrman, S. A., Lasky, L. C., and Limas, C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol., 6: 655-663, 1982.
16. Gnarra, J. R., Duan, D. R., Weng, Y., Humphrey, J. S., Chen, D. Y. T., Le, S., Pause, A., Dudley, C. F., Latif, F., Kuzmin, I., Schmidt, L., Duh, F-M., Stackhouse, T., Chen, F., Kishida, T., Wei, M. H., Lerman, M. I., Zbar, B., Klausner, D. R., and Linehan, W. M. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim. Biophys. Acta, 1242: 201-210, 1996.
17. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54: 1422-1424, 1994.
18. Wang, S. I., Parsons, R., and lttmann, M. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin. Cancer Res., 4: 811-815, 1998.
19. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, M. A., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
20. Negrini, M., Monaco, C., Vorechovsky, J., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The FHIT gene is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
21. Mao, L., Fan, Y. H., Lotan, R., and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5131, 1996.
22. Huebner, K., Hadaczek, P., Siprashvili, Z., Druck, T., and Croce, C. M. The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive fragile site, FRA3B. Biochim. Biophys. Acta, 1332: M65-M70, 1997.
23. Man, S., Ellis, I. O., Sibbering, M., Blamey, R. W., and Brook, J. D. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res., 56: 5484-5489, 1996.
24. Ahmadian, M., Wistuba, I. I., Fong, K. M., Behrens, C., Kodagoda, D. R., Saboorian, M. H., Shay, J., Tomlinson, G. E., Blum, J., Minna, J. D., and Gazdar, A. F. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res., 57: 3664-3668, 1997.
25. Zimonjic, D. B., Druck, T., Ohta, M., Kastury, K., Croce, C. M., and Popescu, N. C. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res., 57: 1166-1170, 1997.
26. Wilke, M. C., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extended over a broad region and contains a spontaneous HPV integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5: 187-195, 1996.
27. Wang, L., Darling, J., Zhang, J. S., Qian, C. P., Hartmann, L., Conover, C., Jenkins, R., and Smith, D. I. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact. Oncogene, 16: 635-642, 1998.
28. Hadaczek, P., Siprashvili, Z., Markiewski, M., Domagala, W., Druck, T., McCue, P., Pekarsky, Y., Ohta, M., Huebner, K., and Lubinski, J. Absence or reduction of FHIT expression in most clear cell renal carcinomas. Cancer Res., 58: 2946-2951, 1998.